The Custom Synthesis and Specialty CDMO industry on FinBizNet covers 13 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 13 |
|---|---|
| Combined market cap | ₹39,339 Cr |
| Median P/E (profitable companies) | 55.3 |
| Median return on equity | 5.6% |
| Companies with latest quarterly results | 9 of 13 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,389 Cr | 73.6 | 5.8% | ₹655 Cr | ₹51 Cr | Q1 FY27 |
| Neogen Chemicals Limited (Neogen) | ₹7,465 Cr | 227.6 | 3.6% | ₹250 Cr | ₹17 Cr | Q1 FY27 |
| Laxmi Organic Industries Ltd | ₹4,963 Cr | 59.9 | 4.1% | ₹968 Cr | ₹68 Cr | Q1 FY27 |
| Tatva Chintan Pharma Chem Ltd | ₹4,547 Cr | 105.8 | 5.5% | ₹217 Cr | ₹21 Cr | Q2 FY27 |
| Prasol Chemicals Limited | ₹4,476 Cr | 50.7 | — | ₹434 Cr | ₹61 Cr | Q1 FY27 |
| Paushak Ltd. | ₹2,046 Cr | 42.9 | 8.2% | ₹84 Cr | ₹15 Cr | Q1 FY27 |
| Sunshield Chemicals Ltd. | ₹906 Cr | 27.7 | 17.0% | — | — | — |
| Chemcon Speciality Chemicals Limited | ₹803 Cr | 33.4 | 4.8% | ₹66 Cr | ₹11 Cr | Q1 FY27 |
| Arvee Laboratories (India) Ltd | ₹249 Cr | 93.9 | 7.8% | ₹17 Cr | ₹2 Cr | Q1 FY27 |
| Resonance Specialties Ltd. | ₹229 Cr | 21.1 | 15.1% | — | — | — |
| Dai-Ichi Karkaria Ltd. | ₹227 Cr | — | -0.4% | — | — | — |
| Vadivarhe Speciality Chemicals Ltd | ₹34 Cr | — | -5.0% | — | — | — |
| Omkar Speciality Chemicals Ltd. | ₹7 Cr | — | 7.7% | ₹0 Cr | ₹-0 Cr | Q1 FY27 |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 13 listed companies in the Custom Synthesis and Specialty CDMO industry, including Anupam Rasayan India Ltd, Neogen Chemicals Limited (Neogen), Laxmi Organic Industries Ltd, Tatva Chintan Pharma Chem Ltd, Prasol Chemicals Limited, Paushak Ltd., Sunshield Chemicals Ltd., Chemcon Speciality Chemicals Limited, among others.
By market capitalisation, the largest Custom Synthesis and Specialty CDMO companies are Anupam Rasayan India Ltd (₹13,389 Cr), Neogen Chemicals Limited (Neogen) (₹7,465 Cr), Laxmi Organic Industries Ltd (₹4,963 Cr), Tatva Chintan Pharma Chem Ltd (₹4,547 Cr), Prasol Chemicals Limited (₹4,476 Cr).
The 13 Custom Synthesis and Specialty CDMO companies tracked on FinBizNet have a combined market capitalisation of about ₹39,339 Cr.
The median price-to-earnings ratio across 10 profitable Custom Synthesis and Specialty CDMO companies is 55.3, and the median return on equity across the industry is 5.6%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Custom Synthesis and Specialty CDMO industry.